Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Apr 1;31(10):1348-56. doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25.

PMID:
23439753
2.

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.

Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJ.

Br J Cancer. 2015 Jun 30;113(1):64-8. doi: 10.1038/bjc.2015.172. Epub 2015 May 19.

3.

Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.

Perysinakis I, Minaidou E, Leontara V, Mantas D, Sotiropoulos GC, Tsipras H, Zografos GN, Margaris I, Kouraklis G.

Int J Surg Pathol. 2017 Feb;25(1):31-40. doi: 10.1177/1066896916664987. Epub 2016 Aug 20.

PMID:
27543509
4.

Histomolecular phenotypes of adenocarcinoma of the ampulla of vater: more evidence is required.

Arroyo GF.

J Clin Oncol. 2013 Oct 20;31(30):3842-3. doi: 10.1200/JCO.2013.50.9331. Epub 2013 Sep 16. No abstract available.

PMID:
24043729
5.

Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.

de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J.

J Gastrointest Surg. 2010 Apr;14(4):719-28. doi: 10.1007/s11605-010-1156-4. Epub 2010 Jan 27.

PMID:
20107918
6.

Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.

Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AV.

J Clin Oncol. 2005 Mar 20;23(9):1811-8.

PMID:
15774774
7.

Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?

Amptoulach S, Josefsson A, Kavantzas N, Kalaitzakis E.

Scand J Gastroenterol. 2011 Nov;46(11):1401-3. doi: 10.3109/00365521.2011.610006. Epub 2011 Aug 19. No abstract available.

PMID:
21854095
8.
9.

Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.

Zhou H, Schaefer N, Wolff M, Fischer HP.

Am J Surg Pathol. 2004 Jul;28(7):875-82.

PMID:
15223956
10.

Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.

Gheza F, Cervi E, Pulcini G, Villanacci V, Giulini SM, Schiavo-Lena M, Ferrari AB, Bassotti G.

Pancreas. 2011 Jul;40(5):791-3. doi: 10.1097/MPA.0b013e318216db94. No abstract available.

PMID:
21673543
11.

Pathogenesis of carcinoma of the papilla of Vater.

Fischer HP, Zhou H.

J Hepatobiliary Pancreat Surg. 2004;11(5):301-9. Review.

PMID:
15549428
12.

The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.

Roh YH, Kim YH, Lee HW, Kim SJ, Roh MS, Jeong JS, Jung GJ.

Hepatogastroenterology. 2007 Sep;54(78):1641-4.

PMID:
18019683
13.

Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.

Yun SP, Seo HI.

BMC Gastroenterol. 2015 Nov 24;15:165. doi: 10.1186/s12876-015-0396-x.

14.

Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.

Kumari N, Prabha K, Singh RK, Baitha DK, Krishnani N.

Hum Pathol. 2013 Oct;44(10):2213-9. doi: 10.1016/j.humpath.2013.05.003. Epub 2013 Jul 5.

PMID:
23834763
15.

Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.

Leo JM, Kalloger SE, Peixoto RD, Gale NS, Webber DL, Owen DA, Renouf D, Schaeffer DF.

J Clin Pathol. 2016 May;69(5):431-9. doi: 10.1136/jclinpath-2015-203337. Epub 2015 Oct 23.

PMID:
26500334
16.

Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.

Jun SY, Eom DW, Park H, Bae YK, Jang KT, Yu E, Hong SM.

Mod Pathol. 2014 Oct;27(10):1364-74. doi: 10.1038/modpathol.2014.36. Epub 2014 Mar 7.

17.
18.

Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.

Kohler I, Jacob D, Budzies J, Lehmann A, Weichert W, Schulz S, Neuhaus P, Röcken C.

Am J Clin Pathol. 2011 Feb;135(2):202-11. doi: 10.1309/AJCPCTCUQSYI89YT.

PMID:
21228360
19.

Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.

Ohike N, Kim GE, Tajiri T, Krasinskas A, Basturk O, Coban I, Bandyopadhyay S, Morohoshi T, Goodman M, Kooby DA, Sarmiento JM, Adsay NV.

Am J Surg Pathol. 2010 Dec;34(12):1731-48. doi: 10.1097/PAS.0b013e3181f8ff05.

20.

Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.

McCarthy DM, Hruban RH, Argani P, Howe JR, Conlon KC, Brennan MF, Zahurak M, Wilentz RE, Cameron JL, Yeo CJ, Kern SE, Klimstra DS.

Mod Pathol. 2003 Mar;16(3):272-8.

Supplemental Content

Support Center